| publication name | Increased Serum Visfatin Levels in Patients with Type2 Diabetic Patients |
|---|---|
| Authors | Osama S El-Shaer, Khaled M Belal, Hesham A Issa, Tawfik El-Adl |
| year | 2012 |
| keywords | |
| journal | |
| volume | Not Available |
| issue | Not Available |
| pages | Not Available |
| publisher | Not Available |
| Local/International | International |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Background: Obesity is highly associated with insulin resistance and the increased risk of type 2 diabetes and cardiovascular diseases. Visfatin is a cytokine that is highly expressed in visceral fat. It's expression in visceral fat is increased in obese subjects. Visfatin exerts insulin-mimetic effects and was as effective as insulin in reducing hyperglycemia in insulin-deficient diabetic mice. Objective: To study serum visfatin level in patients with type2 diabetes mellitus and to clarify its possible relationship with insulin